Cite
HARVARD Citation
Bicakli, D. et al. (n.d.). Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315. Journal of oncology pharmacy practice. pp. 318-319. [Online].